Gene Therapy Innovation and Manufacturing Centre

Accelerating the development of gene therapies into life-changing treatments for patients.

The Gene Therapy Innovation and Manufacturing Centre (GTIMC) has been formed as part of the Innovation Hubs for Gene Therapies. The network of Innovation Hubs for Gene Therapies is a new UK initiative designed to advance the clinical development of new genetic treatments through the production of clinical grade vectors, alongside translational support and regulatory advice.

The Sheffield Innovation Hub will dramatically broaden the scope of gene therapy research in the UK. The Sheffield centre brings together partners from the North of England, the Midlands and Wales to advance knowledge on gene therapies so that we can translate scientific discoveries into new and exciting treatments for patients.

About us

Photo of decal on winder in the Gene Therapy Innovation and Manufacturing Centre

About us

Our partners

Research using lab equipment in the Gene Therapy Innovation and Manufacturing Centre

Our people

What we do

Manufacturing

Process Innovation

scientist in SITraN wearing mask and looking at a sample

Translational Support

Training and Skills

News

11 December 2023

University of Sheffield spinout company to pioneer novel therapies for genetic neurological diseases

BlackfinBio has raised £2.75 million seed investment to advance revolutionary treatments for Hereditary Spastic Paraplegia (HSP).

3 November 2023

New research institute to accelerate the search for a cure for MND

The new UK Motor Neuron Disease Research Institute, or UK MND RI, aims to discover new treatments that could ultimately mean MND becomes a curable condition.

16 October 2023

Strategic partnership for economic growth in South Yorkshire

GTIMC host venue for signing new memorandum of understanding between South Yorkshire Mayoral Combined Authority (SYMCA) and Aviva Capital Partners Limited.

Neuron cells system - 3d rendered image of Neuron cell network on black background

25 September 2023

University of Sheffield spinout company Crucible Therapeutics raises £5 million to advance pioneering treatments for neurological diseases

University of Sheffield spinout company, Crucible Therapeutics, a biotechnology company developing novel therapies to treat the most common genetic form of MND and frontotemporal dementia (FTD), has secured £5 million from Northern Gritstone.